Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 4 completed trials

    Completion Rate
    100%(4/4)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    1
    25%
    Phase 4
    2
    50%
    Early Phase 1
    1
    25%

    Phase Distribution

    2

    Early Stage

    0

    Mid Stage

    2

    Late Stage

    Phase Distribution4 total trials
    Early Phase 1First-in-human
    1(25.0%)
    Phase 1Safety & dosage
    1(25.0%)
    Phase 4Post-market surveillance
    2(50.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    4 of 4 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(4)

    Detailed Status

    Completed4

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Early Phase 11 (25.0%)
    Phase 11 (25.0%)
    Phase 42 (50.0%)

    Trials by Status

    completed4100%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedearly_phase_1

    Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI

    NCT02370862
    completedphase_4

    Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium

    NCT05718934
    completedphase_1

    Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

    NCT04671030
    completedphase_4

    Sugammadex and Brain Waves

    NCT01142648

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT02370862Early Phase 1

    Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI

    Completed
    NCT05718934Phase 4

    Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium

    Completed
    NCT04671030Phase 1

    Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

    Completed
    NCT01142648Phase 4

    Sugammadex and Brain Waves

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4